InvestorsHub Logo
icon url

trader_one

03/08/21 3:39 AM

#85204 RE: Biotechotcguy #85203

In short:

- faster than current alternatives (according to news ~ 1h until results) and amenable to other methods (high throughput, automated)

- the test is highly specific and sensitive AND isotype- and species-independent

The above points are major advantages for the test as it lets us find actual neutralizing antibodies within ANY species in ~ 1h.

How is this relevant for ENZC?

Quote from ceocfointerviews.com:
"Thus, specific antibodies that neutralize are necessary to provide an effective therapy.", Mr. Cotropia

Therefore, IMO, if ENZC needs neutralizing antibodies from (recovered) COVID-19 patients, then knowing who has the neutralizing antibodies with certainty can be a great advantage in reducing time and essentially resources to finding the proper antibodies and eventually creating the cure.

Hope this helps!